Skip to main content

McMurry-Heath Michelle

In the past year, 3 open-market sale filings worth $295.2K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$295.2K
3 filings
Net
−$295.2K
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists McMurry-Heath Michelle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BVS Bioventus Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 13, 2026 (view filing)Mar 112 daysMcMurry-Heath MichelleDirectorSSaleClass A Common Stock−12.0K$8.79−$105.5K−21.1%45.0K after
Nov 10, 2025 (view filing)Nov 73 daysMcMurry-Heath MichelleDirectorSSaleClass A Common Stock−17.7K$7.42−$131.3K−23.7%57.0K after

RVTY Revvity, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 25, 2026 (view filing)Feb 232 daysMcMurry-Heath MichelleDirectorSSale−600$97.26−$58.4K−12.4%4.23K after
May 30, 2025 (view filing)May 291 dayMcMurry-Heath MichelleDirectorSSale−600$92.17−$55.3K−11.0%4.83K after
Feb 7, 2025 (view filing)Feb 61 dayMcMurry-Heath MichelleDirectorSSale−1.97K$119.49−$235.4K−39.5%3.02K after